Biogen is the latest big biotech to make a play in protein degradation. The Massachusetts-based company has announced a deal to use Neomorph’s molecular glue degrader discovery platform to go ...

Biogen has agreed to buy UK-based gene therapy ... is caused by loss of function in the CHM which encodes the Rab escort protein -1 (REP-1), which plays a role in intracellular protein trafficking.

"If we eat a high protein load late in the night, then our stomach produces disproportionately more acid to digest that," Panda said. This combination results in more acid sitting around in the ...

Biogen has ducked out of a four-year-old collaboration ... It inhibits the nuclear export protein exportin-1 (XPO1), the same target as Karyopharm's approved cancer therapy Xpovio (selinexor ...

Oct. 26, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq ... reductions in proteinuria levels as assessed by the urinary protein:creatinine ratio (UPCR) and stabilization of kidney function, as ...